# Cryomass Technologies Inc. (CRYM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CRYM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 25.4K | $ -5.55M | $ -680.2K | $ 3.32M | $ -9.44M |
| 2023 | $ 14.7K | $ -14.01M | $ -4.14M | $ 4.49M | $ -5.85M |
| 2022 | $ 1.04M | $ -11.64M | $ -5.77M | $ 2.00M | $ 4.57M |
| 2021 | $ 0 | $ -15.89M | $ -6.92M | $ 177.1K | $ 13.52M |
| 2020 | $ -1.02M | $ -15.05M | $ -4.78M | $ 464.6K | $ 3.61M |
| 2019 | $ 4.49M | $ -3.95M | $ -2.42M | $ 1.55M | $ 12.44M |
| 2018 | $ 0 | $ -564.0K | $ -597.5K | $ 0 | $ 646.5K |
| 2017 | $ 0 | $ -76.5K | $ 132 | $ 46.2K | $ -177.1K |
| 2016 | $ 0 | $ -60.7K | $ -212 | $ 0 | $ -120.3K |
| 2015 | $ 0 | $ -131.5K | $ -210.1K | $ 0 | $ -76.2K |
| 2014 | $ 919.0K | $ -66.7K | $ -32.4K | $ 138.5K | $ -262.3K |
| 2013 | $ 790.1K | $ -93.4K | $ -1.1K | $ 130.0K | $ -231.3K |
| 2012 | $ 1.28M | $ -44.6K | $ -129.8K | $ 146.6K | $ 175.3K |
| 2011 | $ 778.9K | $ -62.2K | $ 148.9K | $ 108.1K | $ 201.5K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.35 |
| Liabilities / Eq | -1.12 |
| Current Ratio | 0.04 |

## Other views

- [Metrics](https://sponda.capital/en/CRYM.md)
- [Charts](https://sponda.capital/en/CRYM/charts.md)
- [Compare](https://sponda.capital/en/CRYM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.